Viviana García-Horton

Health Economics and Outcomes Research (United Kingdom)

Also affiliated with Analysis Group (United States)

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Adalimumab Is Associated With Lower Healthcare Resource and Steroid Use Versus Vedolizumab in Biologic-Naive Crohn’s Disease: A Retrospective Claims Database Analysis”.

Adalimumab Is Associated With Lower Healthcare Resource and Steroid Use Versus Vedolizumab in Biologic-Naive Crohn’s Disease: A Retrospective Claims Database Analysis

Crohn s & Colitis 360(2022)10.1093/crocol/otac029

N/A

0DataRank · unranked

1 citations

Jenny Griffith, Viviana García-Horton, Aolin Wang, Raymond K. Cross, Ryan C. Ungaro

Comparison of outcomes on hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHIs) in anaemia associated with chronic kidney disease: network meta-analyses in dialysis and non-dialysis dependent populations

Clinical Kidney Journal(2023)10.1093/ckj/sfad298

N/A

0DataRank · unranked

15 citations

Renato D. Lópes, Csaba P. Kövesdy, Aleix Cases, Steve A Mallett, Nick Ballew +8 more